Top

Medicenna Therapeutics Corp.

TSX Exchange | Jul 14, 2020, 12:04 PM EDT | Real-time price

MDNA $ 4.99 RT
CHANGE
-0.01 (-0.20%)
VOLUME
14,146
Day Low: 4.95
Day High: 5.20
Detailed Quote
Open: 5.01
High: 5.20
Beta: N/A
Listed Shares Out.1: 48,797,983
Total Shares (All Classes)2: 48,305,408
Prev. Close: 5.00
Low: 4.95
VWAP: 5.0198
Market Cap1: 243,501,935
Market Cap (All Classes)2*: 241,043,986
Dividend: N/A
Div. Frequency: N/A
P/E Ratio: N/A
EPS: -0.19
Yield: N/A
Ex-Div Date: N/A
P/B Ratio: 99.80
Exchange: TSX

(1) Number based only on listed classes of shares.

(2) Number sourced from third party data provider. For the most up to date information, please refer to the company's financial documents.

*Market Capitalization is based on Total Shares Outstanding for all share classes for the company. Convertible bonds and employee stock options that would otherwise be included in the Diluted Shares amount included in a company's filings/financials are not included.

Description

Medicenna Therapeutics Corp is a Canada based immuno-oncology company. Its principal business activity is the development and commercialization of Empowered Cytokines and Superkines for the treatment of cancer. The company is engaged in developing Interleukin-4 Empowered Cytokines (IL4-ECs) that specifically target the Interleukin-4 Receptor (IL4R) which is over-expressed by 20 different cancers, cancer stem cells and immunosuppressive cells of the tumor microenvironment. The IL4-ECs have the po... More

News Headlines for Medicenna Therapeutics Corp.
Research
News Headlines for Medicenna Therapeutics Corp.
Last 25 Trades
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. View delay times for all exchanges. Market Data powered by QuoteMedia, Fundamentals by Morningstar. See the QuoteMedia Terms of Use.